Netalie has 20 years of professional experience in technology start-up and global corporate environments. Netalie’s interdisciplinary and holistic background, working with start-ups from different vantage points throughout her career, contributes greatly to the evaluation and identification of investment opportunities and portfolio management.
Netalie spent over a decade at Philips in various corporate capacities including Director of Business Development and M&A. She brings with her tremendous transaction and project management experience in investments, strategic partnerships, acquisitions and post-merger integration spanning across several industries including healthcare and consumer health and wellness.
Prior to her time at Philips, Netalie gained experience in a technology start-up and an accelerator that set up companies from stage zero. In both positions, Netalie held senior multidisciplinary CEO support roles where she was responsible for the companies’ business, legal and financial affairs.
Netalie holds a M.S. in Management from Boston University and a B.A. in Legal Studies from the University of California at Berkeley.
Netalie participates on the boards of: Colospan, Day Zero Diagnostics, Genoox, Grin, HealthReveal, Lynx.MD and Tailormed.